Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors
Publication
, Conference
Rizzieri, D; Chute, J; Horwitz, M; Gasparetto, C; Sullivan, K; Long, G; Morris, A; Niedzwiecki, D; Nelson, C
Published in: Biology of Blood and Marrow Transplantation
February 2006
Duke Scholars
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2006
Volume
12
Issue
2
Start / End Page
34 / 34
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rizzieri, D., Chute, J., Horwitz, M., Gasparetto, C., Sullivan, K., Long, G., … Nelson, C. (2006). Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors. In Biology of Blood and Marrow Transplantation (Vol. 12, pp. 34–34). Elsevier BV. https://doi.org/10.1016/j.bbmt.2005.11.104
Rizzieri, D., J. Chute, M. Horwitz, C. Gasparetto, K. Sullivan, G. Long, A. Morris, D. Niedzwiecki, and C. Nelson. “Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors.” In Biology of Blood and Marrow Transplantation, 12:34–34. Elsevier BV, 2006. https://doi.org/10.1016/j.bbmt.2005.11.104.
Rizzieri D, Chute J, Horwitz M, Gasparetto C, Sullivan K, Long G, et al. Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2006. p. 34–34.
Rizzieri, D., et al. “Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors.” Biology of Blood and Marrow Transplantation, vol. 12, no. 2, Elsevier BV, 2006, pp. 34–34. Crossref, doi:10.1016/j.bbmt.2005.11.104.
Rizzieri D, Chute J, Horwitz M, Gasparetto C, Sullivan K, Long G, Morris A, Niedzwiecki D, Nelson C. Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors. Biology of Blood and Marrow Transplantation. Elsevier BV; 2006. p. 34–34.
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2006
Volume
12
Issue
2
Start / End Page
34 / 34
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences